Please login to the form below

Not currently logged in
Email:
Password:

Lilly invests in biotechnology

Eli Lilly & Company has announced a multi-million dollar investment to expand its existing biotechnology capabilities in the US

Eli Lilly & Company has announced a multi-million dollar investment to expand its existing biotechnology capabilities in the US.

The investment will support research and development of multi-specific therapeutics, in which two or more distinct mechanisms of action are engineered in one molecule with the goal of providing enhanced efficacy with an improved safety profile.

Lilly said it is hiring additional biochemists and biologists to work at its biotechnology facilities in Indianapolis and San Diego.

Dr Jan M Lundberg, Lilly's executive vice president of science and technology and president of Lilly Research Laboratories, said: "Our further investment in multi-specific therapeutics underscores Lilly's commitment to the field of biotechnology and its importance to providing improved outcomes for individual patients."

Lilly's protein engineering expertise has been built internally in its Indianapolis biotechnology research group and through the earlier acquisition of Applied Molecular Evolution (AME).

Lilly is also analysing its historic library of protein and antibody assets, a compilation of molecules from decades of research in Lilly Research Laboratories, AME and ImClone, to determine their potential to be engineered into multi-specific therapeutics.

29th June 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...

Infographics